References
- Klein DF. 1964. Delineation of two drug-responsive anxiety syndromes. Psychopharmacologia. 5:397–408.
- Komossa K, Depping AM, Gaudchau A, Kissling W, Leucht S. 2010. Second-generation antipsychotics for major depressive disorder and dysthymia. Cochrane Database Syst Rev. 12:CD008121.
- Zohar J, Allgulander C. 2011. Antipsychotics in anxiety disorders: an oxymoron or a reflection of non-adequate nomenclature? Eur Neuropsychopharmacol. 21:427–428.
- Zohar J, Nutt DJ, Kupfer DJ, Moller HJ, Yamawaki S, Spedding M, Stahl SM. 2014. A proposal for an updated neuropsychopharmacological nomenclature. Eur Neuropsychopharmacol. 24:1005–1014.
- Zohar J, Stahl S, Moller HJ, Blier P, Kupfer D, Yamawaki S, Uchida H, Spedding M, Goodwin GM, Nutt D. 2015. A review of the current nomenclature for psychotropic agents and an introduction to the neuroscience-based nomenclature. Euro Neuropsychopharmacol. 25:2318–2325.